Effect of a Topical Nonsteroidal Anti-Inflammatory Drug (0.1% Pranoprofen) on VEGF and COX-2 Expression in Primary Pterygium

• Published in: Frontiers in pharmacology Vol. 12; p. 709251
• Main Authors: Yao, Bangtao, Wang, Fei, Zhao, Xiaogui, Wang, Bei, Yue, Xiaoli, Ding, Yuhua, Liu, Gang
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 09.07.2021
• Subjects: 01% Pranoprofen; cyclo-oxygen-ase-2; nonsteroidal anti-inflammatory drug; Pharmacology; pterygium; vascular endothelial growth factor; 01% Pranoprofen; pterygium; cyclo-oxygen-ase-2; vascular endothelial growth factor; nonsteroidal anti-inflammatory drug

To evaluate the effect of a topical nonsteroidal anti-inflammatory drug (0.1% pranoprofen) on the expression of VEGF and Cox-2 in primary pterygium. This was a prospective, randomized study. Between January 2019 and April 2020, 120 patients diagnosed with primary pterygium were enrolled and randomly...